3060 PEGASUS PARK DRIVE, DALLAS, TX
Completion of Acquisition - Forte Biosciences Enters Merger Agreement
Ex-99.1
Investor Presentation
News, Material Contracts
ANNOUNCES FIRST QUARTER 2026 RESULTS AND PROVIDES UPDATE
Annual Report to Security Holders
Announces Pricing of $150 Million Public Offering
Announces 2025 Results and Provides Update
Q2
Q1
FY 2025
Q3
FY 2024
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Definitive Additional Information Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Notification Filed by a National Security Exchange
Statement of Changes in Beneficial Ownership
S-8 POS
Amended Tender Offer Statement by Third Party
Amended Schedule 14D-9 Solicitation/Recommendation Statement